GI
AUPH icon

GAMMA Investing’s Aurinia Pharmaceuticals AUPH Stock Holding History

GAMMA Investing’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$86.1K Buy
5,317
+967
+22% +$15.4K ﹤0.01% 1976
2026
Q2 		$73.8K Buy
4,350
+90
+2% +$1.44K ﹤0.01% 2039
2026
Q1 		$63.1K Buy
4,260
+455
+12% +$6.65K ﹤0.01% 2026
2025
Q4 		$60.7K Buy
3,805
+213
+6% +$3.02K ﹤0.01% 1938
2025
Q3 		$39.7K Buy
3,592
+548
+18% +$5.99K ﹤0.01% 2145
2025
Q2 		$25.8K Sell
3,044
-1,808
-37% -$14.5K ﹤0.01% 2330
2025
Q1 		$39K Buy
4,852
+1,744
+56% +$14.1K ﹤0.01% 1969
2024
Q4 		$27.9K Buy
3,108
+308
+11% +$2.51K ﹤0.01% 2087
2024
Q3 		$20.5K Buy
2,800
+1,587
+131% +$9.84K ﹤0.01% 2092
2024
Q2 		$6.93K Sell
1,213
-1,556
-56% -$8.2K ﹤0.01% 2422
2024
Q1 		$13.9K Buy
2,769
+1,991
+256% +$13.5K ﹤0.01% 1874
2023
Q4 		$5.87K Buy
+778
New +$6.41K ﹤0.01% 2163

Other funds holding AUPH

JWS
Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return
AIM
Acropolis Investment Management St. Louis, Missouri $2.49B AUM 10.8% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's AUPH Position: Q3 2026 in Review

GAMMA Investing increased its Aurinia Pharmaceuticals (AUPH) stake by 22% in Q3 2026, buying an estimated $15.4K and bringing the position to 5,317 shares worth $86.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1976.

GAMMA Investing first reported a position in AUPH in Q4 2023 and has held it in 12 quarters since. 5 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • GAMMA Investing held 5,317 shares of Aurinia Pharmaceuticals worth $86.1K as of Q3 2026.
  • GAMMA Investing bought 967 Aurinia Pharmaceuticals shares in Q3 2026, an estimated $15.4K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #1976 holding.
  • GAMMA Investing first reported a position in Aurinia Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 5 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.